Atopic Dermatitis: Research and Clinical Updates and Perspectives

doi:10.3390/books978-3-0365-9205-3

Download Url(s)

https://mdpi.com/books/pdfview/book/8143

Contributor(s)

Gregoriou, Stamatis (editor)

Language

English

Show full item record

Abstract

This Special Issue on Atopic Dermatitis focuses on novel insights into the pathogenesis of the immunological components of the disorder and the impaired epidermal barrier properties. It also explores the efficacy and safety of breakthrough therapies with topical agents and systemic therapies, such as monoclonals and JAK inhibitors. The aim of this Special Issue is also to present the expected future forefront of research and the treatment options that are expected to be available in the next few years.

URI

https://directory.doabooks.org/handle/20.500.12854/128681

Keywords

atopic dermatitis; dupilumab; skin barrier; transepidermal water loss; n/a; dexpanthenol; topical corticosteroid; emollient; psoriasis; mesenchymal stem cells; biologics; therapy; regenerative medicine; topical treatment; JAK inhibitors; PDE-4 inhibitors; information campaign; early diagnosis; comorbidities; patterns; network analysis; cancer; real-world study; biological therapy; human epidermis; immunofluorescence; transmission electron microscopy; keratinocytes; interleukins; toll-like receptors; human beta-defensin 2; involucrin; filaggrin; claudin-1; exposome; age; skin of color; COVID-19; war; intrinsic atopic dermatitis; atopic; child; dermatitis; family; quality of life; narrow-band UVB phototherapy; ultraviolet A1 phototherapy